• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Uniqure Ord Shs (NQ: QURE )

    7.740 -0.060 (-0.77%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,504,577
    Open 7.920
    Bid (Size) 7.500 (2)
    Ask (Size) 7.860 (2)
    Prev. Close 7.800
    Today's Range 7.590 - 7.960
    52wk Range 3.730 - 11.35
    Shares Outstanding 48,549,437
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Are UniQure Shares Surging Today?
    UniQure N.V. (NASDAQ: QURE) shares are skyrocketing Wednesday following the release of promising interim data from its Phase I/II clinical trials of AMT-130, a gene therapy targeting Huntington's... 
    Via Benzinga

    Performance

    YTD
    +11.69%
    +11.69%
    1 Month
    +69.74%
    +69.74%
    3 Month
    +65.74%
    +65.74%
    6 Month
    +39.46%
    +39.46%
    1 Year
    -22.21%
    -22.21%

    More News

    Read More
    Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Recap: uniQure Q4 Earnings
    Via Benzinga
    SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    S&P 500 Edges Higher; Indivior Shares Plummet
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Crude Oil Down 1%; Soligenix Shares Surge
    Via Benzinga
    Exposures Fossil Fuels
    Why UniQure Stock Is Soaring
    Via Benzinga
    MULN Stock Alert: Mullen Announces EV Sale to Spencer Manufacturing
    Via InvestorPlace
    Why Is uniQure (QURE) Stock Up 51% Today?
    Via InvestorPlace
    Dow Falls Over 50 Points; US Small Business Optimism Surges In June
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
    From uniQure Inc.
    Via GlobeNewswire
    uniQure Announces Sale of Commercial Manufacturing Facility to Genezen
    From uniQure Inc.
    Via GlobeNewswire
    uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease
    From uniQure Inc.
    Via GlobeNewswire
    QURE Stock Earnings: uniQure Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
    From uniQure Inc.
    Via GlobeNewswire
    Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy
    Via Investor's Business Daily
    Exposures Product Safety
    AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    uniQure Announces 2023 Financial Results and Highlights Recent Company Progress
    From uniQure Inc.
    Via GlobeNewswire
    Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
    From uniQure Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.